Differentiation of human alloreactive CD4+ and CD8+T cells in vitro

Transplantation

Volumn 78, Issue 6, 2004, Pages 815-824

  Nikolaeva, Natalia ^a   Uss, Elena ^a   Van Leeuwen, Ester M M ^a   Van Lier, René A W ^a   Ten Berge, Ineke J M ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cellular differentiation; Human; Memory; T lymphocytes

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7;

ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; LYMPHOCYTE DIFFERENTIATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL SEPARATION; COCULTURE TECHNIQUES; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; GRAFT REJECTION; HUMANS; LYMPHOCYTE ACTIVATION; SUCCINIMIDES; TRANSPLANTATION, HOMOLOGOUS;

EID: 4644293264     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000133308.60226.FA     Document Type: Article

References (31)

1. Hall BM, Dorsch SE. Cells mediating allograft rejection. Immunol Rev 1984; 77: 31-59.
2. Li XC, Strom TB, Turka LA, et al. T cell death and transplantation tolerance. Immunity 2001; 14: 407-416.
3. van Lier RA, ten Berge IJ, Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol 2003; 3: 1-8.
4. + T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis 2000; 182: 451-458.
5. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168: 3660-3666.
6. Gamadia LE, van Leeuwen EM, Remmerswaal EB, et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol 2004; 172: 6107-6114.
7. + T cells in protection against CMV disease. Blood 2003; 101: 2686-2692.
8. + T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 1996; 88: 3513-3521.
9. Gamadia LE, Rentenaar RJ, Baars PA, et al. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001; 98: 754-761.
10. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410: 106-111.
11. Tomiyama H, Matsuda T, Takiguchi M. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J Immunol 2002; 168: 5538-5550.
12. Campbell JJ, Murphy KE, Kunkel EJ, et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001; 166: 877-884.
13. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002; 168: 5954-5958.
14. Rentenaar RJ, Gamadia LE, van DerHoek N, et al. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest 2000; 105: 541-548.
15. +, CMV-specific T cell subset after recovery of primary CMV infection. J Immunol 2004; 173: 1834-1841.
16. + T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 2003; 198: 903-911.
17. Game DS, Lechler RI. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 2002; 10: 101-108.
18. Merkenschlager M, Terry L, Edwards R, et al. Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation. Eur J Immunol 1988; 18: 1653-1661.
19. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333-358.
20. Braun MY, McCormack A, Webb G, et al. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177-182.
21. + cells are essential for allorejection. J Exp Med 1996; 184: 2013-2018.
22. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-1151.
23. Rosenberg AS, Mizuochi T, Singer A. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts: assessment of MHC class I alloantigens as in vivo helper determinants. J Exp Med 1988; 168: 33-45.
24. Sprent J, Schaefer M, Lo D, et al. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 998-1011.
25. Halamay KE, Kirkman RL, Sun L, et al. CD8 T cells are sufficient to mediate allorecognition and allograft rejection. Cell Immunol 2002; 216: 6-14.
26. He X, Janeway CA Jr, Levine M, et al. Dual receptor T cells extend the immune repertoire for foreign antigens. Nat Immunol 2002; 3: 127-134.
27. Foulds KE, Zenewicz LA, Shedlock DJ, et al. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol 2002; 168: 1528-1532.
28. + T-cell memory. Nat Med 2001; 7: 913-919.
29. Whitmire JK, Flavell RA, Grewal IS, et al. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol 1999; 163: 3194-3201.
30. Yasukawa M, Ohminami H, Arai J, et al. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Blood 2000; 95: 2352-2355.
31. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379-385.